| Asia Talent Chemical Limited | China | Inquire | ||
|---|---|---|---|---|
![]() | www.atchem.net | |||
![]() | +86 (755) 8665-5561 | |||
![]() | +86 (755) 8665-5591 | |||
![]() | jeffreyxu@atchem.net sinochemxu@hotmail.com asiatalentchem@gmail.com | |||
![]() | QQ Chat | |||
![]() | Skype Chat | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2007 | ||||
| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
![]() | www.simagchem.com | |||
![]() | +86 13806087780 | |||
![]() | +86 (592) 268-0237 | |||
![]() | sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink Standard supplier since 2008 | ||||
| Hefei TNJ Chemical Industry Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.tnjchem.com | |||
![]() | +86 (551) 6541-8684 | |||
![]() | +86 (551) 6541-8697 | |||
![]() | sales@tnjchem.com | |||
| Chemical manufacturer since 2001 | ||||
| chemBlink Standard supplier since 2010 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.bocsci.com | |||
![]() | +1 (631) 485-4226 | |||
![]() | +1 (631) 614-7828 | |||
![]() | info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.scbt.com | |||
![]() | +1 (831) 457-3800 | |||
![]() | +1 (831) 457-3801 | |||
![]() | scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Actylis | USA | Inquire | ||
|---|---|---|---|---|
![]() | actylis.com | |||
![]() | +1 (516) 627-6000 | |||
![]() | +1 (516) 627-6093 | |||
![]() | info@actylis.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Circulatory system medication >> Antiarrhythmic drug |
|---|---|
| Name | Antazoline hydrochloride |
| Synonyms | 2-(N-Benzylanilinomethyl)-2-imidazoline hydrochloride |
| Molecular Structure | ![]() |
| Molecular Formula | C17H19N3.HCl |
| Molecular Weight | 301.82 |
| CAS Registry Number | 2508-72-7 |
| EC Number | 219-719-8 |
| Hazard Symbols | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R20/21/22;R36/37/38 Details | ||||||||||||||||||||||||||||||||
| Safety Statements | S26;S36 Details | ||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Antazoline hydrochloride |